Joanne M. Langley

13.8k total citations · 5 hit papers
237 papers, 7.9k citations indexed

About

Joanne M. Langley is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Joanne M. Langley has authored 237 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 151 papers in Epidemiology, 64 papers in Infectious Diseases and 41 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Joanne M. Langley's work include Respiratory viral infections research (69 papers), Influenza Virus Research Studies (68 papers) and Pneumonia and Respiratory Infections (54 papers). Joanne M. Langley is often cited by papers focused on Respiratory viral infections research (69 papers), Influenza Virus Research Studies (68 papers) and Pneumonia and Respiratory Infections (54 papers). Joanne M. Langley collaborates with scholars based in Canada, United States and Belgium. Joanne M. Langley's co-authors include Scott A. Halperin, Shelly McNeil, Dena L. Schanzer, Theresa Tam, Seyed M. Moghadas, Simon Dobson, Alison P. Galvani, Donna MacKinnon‐Cameron, François D. Boucher and Bruce R. Smith and has published in prestigious journals such as New England Journal of Medicine, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Joanne M. Langley

228 papers receiving 7.5k citations

Hit Papers

Respiratory Syncytial Vir... 2017 2026 2020 2023 2023 2021 2017 2017 2025 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joanne M. Langley Canada 48 4.6k 2.5k 1.3k 965 898 237 7.9k
Katherine A. Poehling United States 38 6.5k 1.4× 1.7k 0.7× 1.8k 1.4× 732 0.8× 492 0.5× 87 7.6k
Jay C. Butler United States 53 6.0k 1.3× 2.6k 1.0× 1.3k 1.0× 2.1k 2.2× 1.3k 1.4× 133 10.5k
Andrew T. Pavia United States 55 6.2k 1.4× 2.9k 1.2× 1.4k 1.1× 858 0.9× 960 1.1× 208 10.0k
Flor M. Muñoz United States 44 3.8k 0.8× 1.7k 0.7× 621 0.5× 1.2k 1.3× 614 0.7× 205 6.8k
Grace M. Lee United States 54 4.0k 0.9× 3.3k 1.3× 545 0.4× 1.4k 1.4× 667 0.7× 205 9.9k
Cheryl Cohen South Africa 43 4.4k 1.0× 3.1k 1.3× 616 0.5× 581 0.6× 429 0.5× 253 7.7k
Christopher C. Blyth Australia 41 3.5k 0.8× 2.2k 0.9× 788 0.6× 414 0.4× 563 0.6× 282 5.5k
Kim Mulholland United Kingdom 49 6.6k 1.4× 1.5k 0.6× 947 0.7× 2.7k 2.8× 1.3k 1.5× 279 10.1k
Mark C. Steinhoff United States 43 5.4k 1.2× 1.4k 0.6× 1.1k 0.9× 1.6k 1.7× 617 0.7× 137 7.8k
Lisa A. Grohskopf United States 39 5.9k 1.3× 3.0k 1.2× 444 0.4× 636 0.7× 699 0.8× 70 8.7k

Countries citing papers authored by Joanne M. Langley

Since Specialization
Citations

This map shows the geographic impact of Joanne M. Langley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne M. Langley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne M. Langley more than expected).

Fields of papers citing papers by Joanne M. Langley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanne M. Langley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne M. Langley. The network helps show where Joanne M. Langley may publish in the future.

Co-authorship network of co-authors of Joanne M. Langley

This figure shows the co-authorship network connecting the top 25 collaborators of Joanne M. Langley. A scholar is included among the top collaborators of Joanne M. Langley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanne M. Langley. Joanne M. Langley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fitzpatrick, Tiffany, Shelly Bolotin, Sarah A. Buchan, et al.. (2026). Parental acceptability of new RSV preventive therapies for infants: A cross-sectional survey in Canada. Human Vaccines & Immunotherapeutics. 22(1). 2588016–2588016.
2.
Sumsuzzman, Dewan Md., Yang Ye, Zhen Wang, et al.. (2025). Impact of disease severity, age, sex, comorbidity, and vaccination on secondary attack rates of SARS-CoV-2: a global systematic review and meta-analysis. BMC Infectious Diseases. 25(1). 215–215.
3.
Coleman, Brenda L., Iris Gutmanis, Susan J. Bondy, et al.. (2024). Canadian health care providers' and education workers' hesitance to receive original and bivalent COVID-19 vaccines. Vaccine. 42(24). 126271–126271. 4 indexed citations
4.
Vesikari, Timo, Joanne M. Langley, Johanna N. Spaans, et al.. (2023). The persistence of seroprotective levels of antibodies after vaccination with PreHevbrio, a 3-antigen hepatitis B vaccine. Vaccine. 41(24). 3584–3588. 9 indexed citations
5.
Ison, Michael G., Alberto Papi, Joanne M. Langley, et al.. (2023). A Respiratory Syncytial Virus (RSV) Prefusion F Protein Candidate Vaccine (RSVPreF3-OA) is Efficacious in Adults ≥ 60 Years of Age (YOA). Diabetologie und Stoffwechsel. 18(S 01). S54–S54. 2 indexed citations
6.
Vesikari, Timo, et al.. (2023). PreHevbrio: the first approved 3-antigen hepatitis B vaccine. Expert Review of Vaccines. 22(1). 1041–1054. 9 indexed citations
7.
Langley, Joanne M., Soren Gantt, Scott A. Halperin, et al.. (2023). An enveloped virus-like particle alum-adjuvanted cytomegalovirus vaccine is safe and immunogenic: A first-in-humans Canadian Immunization Research Network (CIRN) study. Vaccine. 42(3). 713–722. 11 indexed citations
8.
Conly, John, Jeannette Comeau, Joanne Embreé, et al.. (2022). Cerebrospinal fluid shunt–associated surgical site infection with three-month versus twelve-month surveillance periods in Canadian hospitals. Infection Control and Hospital Epidemiology. 44(6). 971–974.
9.
Moghadas, Seyed M., Thomas N. Vilches, Kevin Zhang, et al.. (2021). The Impact of Vaccination on Coronavirus Disease 2019 (COVID-19) Outbreaks in the United States. Clinical Infectious Diseases. 73(12). 2257–2264. 348 indexed citations breakdown →
10.
Beernink, Peter T., Joanne M. Langley, Soren Gantt, et al.. (2019). Anti-Factor H Antibody Reactivity in Young Adults Vaccinated with a Meningococcal Serogroup B Vaccine Containing Factor H Binding Protein. mSphere. 4(4). 10 indexed citations
11.
Woolcott, Christy, et al.. (2017). Risk factors for surgical site infection following cesarean delivery: a retrospective cohort study. CMAJ Open. 5(3). E546–E556. 27 indexed citations
12.
Smith, Steven M., et al.. (2016). The role of healthcare provider attitudes in increasing willingness to accept seasonal influenza vaccine policy changes. Vaccine. 34(47). 5704–5707. 4 indexed citations
13.
Boyd, David A., Geoffrey Taylor, Jeff Fuller, et al.. (2014). Complete Sequence of Four Multidrug-Resistant MOB Q1 Plasmids Harboring bla GES-5 Isolated from Escherichia coli and Serratia marcescens Persisting in a Hospital in Canada. Microbial Drug Resistance. 21(3). 253–260. 14 indexed citations
14.
Coleman, Brenda L., Allison McGeer, Scott A. Halperin, et al.. (2012). A randomized control trial comparing immunogenicity, safety, and preference for self- versus nurse-administered intradermal influenza vaccine. Vaccine. 30(44). 6287–6293. 27 indexed citations
15.
Langley, Joanne M., Naresh Aggarwal, David A. Connor, et al.. (2012). Randomized, Multicenter Trial of a Single Dose of AS03-adjuvanted or Unadjuvanted H1N1 2009 Pandemic Influenza Vaccine in Children 6 Months to <9 Years of Age. The Pediatric Infectious Disease Journal. 31(8). 848–858. 13 indexed citations
16.
Matlow, Anne, Sarah Forgie, Linda Pelude, et al.. (2012). National Surveillance of Methicillin-resistant Staphylococcus aureus Among Hospitalized Pediatric Patients in Canadian Acute Care Facilities, 1995–2007. The Pediatric Infectious Disease Journal. 31(8). 814–820. 16 indexed citations
17.
Perrett, Kirsten P., Matthew D. Snape, Karen Ford, et al.. (2009). Immunogenicity and Immune Memory of a Nonadjuvanted Quadrivalent Meningococcal Glycoconjugate Vaccine in Infants. The Pediatric Infectious Disease Journal. 28(3). 186–193. 52 indexed citations
18.
Langley, Joanne M., et al.. (2008). Acute Febrile Illness and a Splenic Mass in a 15‐Year‐Old West African Immigrant. Canadian Journal of Infectious Diseases and Medical Microbiology. 19(4). 311–312. 1 indexed citations
19.
Schanzer, Dena L., Joanne M. Langley, & Theresa Tam. (2008). Role of influenza and other respiratory viruses in admissions of adults to Canadian hospitals. Influenza and Other Respiratory Viruses. 2(1). 1–8. 66 indexed citations
20.
Arnold, Sandra R., Elaine E. L. Wang, Barbara Law, et al.. (1999). Variable morbidity of respiratory syncytial virus infection in patients with underlying lung disease: a review of the PICNIC RSV database. The Pediatric Infectious Disease Journal. 18(10). 866–869. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026